I agree that this site is using cookies. You can find further informations here.
X
Giersing, Birgitte K.
85  results:
Search for persons X
?
1

The role of vaccines in reducing antimicrobial resistance: ..:

Hasso-Agopsowicz, Mateusz ; Sparrow, Erin ; Cameron, Alexandra Meagan...
Vaccine.  42 (2024)  19 - p. S1-S8 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Facilitating the development of urgently required combinati..:

Hausdorff, William P ; Madhi, Shabir A ; Kang, Gagandeep...
The Lancet Global Health.  12 (2024)  6 - p. e1059-e1067 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Clinical and regulatory development strategies for Shigella..:

Giersing, Birgitte K ; Isbrucker, Richard ; Kaslow, David C...
The Lancet Global Health.  11 (2023)  11 - p. e1819-e1826 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Challenges and opportunities in developing a Shigella-conta..:

Riddle, Mark S. ; Louis Bourgeois, A. ; Clifford, Allison...
Vaccine.  41 (2023)  16 - p. 2634-2644 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Vaccine value profile for Shigella:

Hausdorff, William P. ; Anderson IV, John D. ; Bagamian, Karoun H....
Vaccine.  41 (2023)  - p. S76-S94 , 2023
Link: https://doi.org/10.1016/..
 
?
6

What Drives the Value of a Shigella Vaccine?:

Hausdorff, William P. ; Scheele, Suzanne ; Giersing, Birgitte K.
Vaccines.  10 (2022)  2 - p. 282 , 2022
Link: https://doi.org/10.3390/..
 
?
7

Pivotal Shigella Vaccine Efficacy Trials—Study Design Consi..:

Pavlinac, Patricia B. ; Rogawski McQuade, Elizabeth T. ; Platts-Mills, James A....
Vaccines.  10 (2022)  4 - p. 489 , 2022
Link: https://doi.org/10.3390/..
 
?
8

World Health Organization Expert Working Group: Recommendat..:

Hasso-Agopsowicz, Mateusz ; Lopman, Benjamin A. ; Lanata, Claudio F....
Vaccine.  39 (2021)  52 - p. 7521-7525 , 2021
Link: https://doi.org/10.1016/..
 
?
9

The CAPACITI Decision-Support Tool for National Immunizatio..:

Botwright, Siobhan ; Giersing, Birgitte K. ; Meltzer, Martin I....
Value in Health.  24 (2021)  8 - p. 1150-1157 , 2021
Link: https://doi.org/10.1016/..
 
?
10

Global diarrhoea-associated mortality estimates and models ..:

Butkeviciute, Egle ; Prudden, Holly J. ; Jit, Mark...
Vaccine.  39 (2021)  32 - p. 4391-4398 , 2021
Link: https://doi.org/10.1016/..
 
?
11

Critical Needs in Advancing Shigella Vaccines for Global He..:

MacLennan, Calman A ; Talaat, Kawsar R ; Kaminski, Robert W...
The Journal of Infectious Diseases.  225 (2021)  9 - p. 1500-1503 , 2021
Link: https://doi.org/10.1093/..
 
?
12

How can we evaluate the potential of innovative vaccine pro..:

Botwright, Siobhan ; Kahn, Anna-Lea ; Hutubessy, Raymond...
Vaccine: X.  6 (2020)  - p. 100078 , 2020
Link: https://doi.org/10.1016/..
 
?
13

Gonococcal vaccines: Public health value and preferred prod..:

Gottlieb, Sami L. ; Ndowa, Francis ; Hook III, Edward W....
Vaccine.  38 (2020)  28 - p. 4362-4373 , 2020
Link: https://doi.org/10.1016/..
 
?
14

Considerations for using ETEC and Shigella disease burden e..:

Hosangadi, Divya ; Smith, Peter G. ; Giersing, Birgitte K.
Vaccine.  37 (2019)  50 - p. 7372-7380 , 2019
Link: https://doi.org/10.1016/..
 
?
15

Report from the World Health Organization's third Product D..:

Giersing, Birgitte K. ; Vekemans, Johan ; Nava, Samantha..
Vaccine.  37 (2019)  50 - p. 7315-7327 , 2019
Link: https://doi.org/10.1016/..
 
1-15